<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Immune System Therapeutics</title>
	<atom:link href="http://www.istl.com.au/cms/?feed=rss2" rel="self" type="application/rss+xml" />
	<link>http://www.istl.com.au/cms/</link>
	<description></description>
	<lastBuildDate>Tue, 17 Apr 2012 23:34:58 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
<xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" />
		<item>
		<title>Australian myeloma patients are the first in the world to access a new experimental drug, MDX-1097.</title>
		<link>http://www.istl.com.au/cms//?p=398&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=australian-myeloma-patients-are-the-first-in-the-world-to-access-a-new-experimental-drug-mdx-1097</link>
		<comments>http://www.istl.com.au/cms//?p=398#comments</comments>
		<pubDate>Fri, 06 Jan 2012 07:30:45 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.istl.com.au/cms//?p=398</guid>
		<description><![CDATA[Article extracted from Myeloma news September 2011 Publication NEW TRIAL DRUG FOR MYELOMA Australian myeloma patients are the first in the world to access a new experimental drug, MDX-1097. The Alfred Hospital in Melbourne is recruiting patients with kappa-type myeloma &#8230; <a href="http://www.istl.com.au/cms//?p=398">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.istl.com.au/cms//?feed=rss2&#038;p=398</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Australian anti-cancer drug company granted important new patent</title>
		<link>http://www.istl.com.au/cms//?p=359&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=australian-anti-cancer-drug-company-granted-important-new-patent-3</link>
		<comments>http://www.istl.com.au/cms//?p=359#comments</comments>
		<pubDate>Wed, 14 Sep 2011 04:26:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.istl.com.au/cms/?p=359</guid>
		<description><![CDATA[ Sydney, Australia, 31 August 2011; Australian monoclonal antibody company, Immune System Therapeutics Limited (IST), today announced it had secured patent protection inAustralia for a new method of treating blood cancers that express a target called lambda myeloma antigen (LMA), which &#8230; <a href="http://www.istl.com.au/cms//?p=359">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.istl.com.au/cms//?feed=rss2&#038;p=359</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Multiple Myeloma Patient Goes into Remission in Response to MDX-1097 Treatment</title>
		<link>http://www.istl.com.au/cms//?p=261&#038;utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=multiple-myeloma-patient-goes-into-remission-in-response-to-mdx-1097-treatment</link>
		<comments>http://www.istl.com.au/cms//?p=261#comments</comments>
		<pubDate>Tue, 28 Jun 2011 05:51:30 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[media]]></category>

		<guid isPermaLink="false">http://www.danbeazley.com.au/wordpressplay/?p=261</guid>
		<description><![CDATA[Christine Marr with her dog Albert. Picture: Chris Scott. Source: Herald Sun AN Australian treatment has shown great promise in treating an incurable blood cancer after a grandmother went into remission. Christine Marr, a grandmother of six of Mt Martha, &#8230; <a href="http://www.istl.com.au/cms//?p=261">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.istl.com.au/cms//?feed=rss2&#038;p=261</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

